Deina Walsh - Jan 17, 2024 Form 4 Insider Report for Bone Biologics Corp (BBLG)

Role: Chief Financial Officer
Signature: /s/ Deina Walsh
Stock symbol: BBLG
Transactions as of: Jan 17, 2024
Transactions value $: $0
Form type: 4
Date filed: 1/19/2024, 05:24 PM
Previous filing: Sep 14, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BBLG	Common Stock						1.88K	Jan 17, 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BBLG	Employee Stock Option	Award	$0	+12.5K		$0.00	12.5K	Jan 17, 2024	Common Stock	12.5K	$3.61	Direct	F1
holding	BBLG	Employee Stock Option						78	Jan 17, 2024	Common Stock	78	$57.60	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable immediately.
F2	This option is fully vested as of the date of this report.